Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Deadline 25 Aug 2026 - 23:59 (Europe/Brussels) Country Belgium Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
) and ATTR (transthyretin) amyloidosis are the most common systemic forms, with distinct molecular origins but shared mechanisms of extracellular amyloid deposition and tissue damage. Our research program
-
7 Apr 2026 Job Information Organisation/Company VIB Research Field Biological sciences Computer science Researcher Profile Leading Researcher (R4) Positions Other Positions Application Deadline 31
-
, computational biologists, and experimental partners in both academia and industry to advance translational projects towards partnerships, or venture creation. Your profile PhD with 5+ years of postdoctoral and/or
-
for Cancer Biology: https://www.vibcancer.be VIB Center for AI and Computational Biology: https://vib.ai/ For questions: jonas.demeulemeester@kuleuven.be KU Leuven and VIB aim to be inclusive, respectful and
-
validation, engineering, and valorization pathways such as licensing, partnerships, and spin‑outs. About the role We are seeking a Senior Computational Biology Scientist in AI Protein Structure Prediction and
-
will be working closely together with PhD students and postdoctoral researchers, coming from both computational and biological backgrounds. Because of the interdisciplinary nature of our lab, we
-
Dendooven Lab — VIB–VUB Center for Structural Biology (CSB), Brussels, Belgium Start date: Flexible | Duration: 4 years | Funding: ERC Starting Grant Description We are seeking a postdoctoral fellow
-
Description We are seeking a motivated new PhD candidate or Postdoctoral fellow who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between
-
Description We are seeking a motivated new PhD candidate or Postdoctoral fellow who wants to join an exciting collaborative research program within the VIB-Center for Inflammation Research between